OWKIN

Summary

Owkin is an end-to-end TechBio company that uses AI to identify new treatments, de-risk and accelerate clinical trials and build diagnostic tools.

Deals Overview

Total Deals3

Valued Deals3

Total Value£ 174 M

Avg. Deal Size£ 58 M

Market Context

Senior Management